These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17033201)

  • 1. Evaluation of an improved tissue inhibitor of metalloproteinase 1 dual monoclonal sandwich immunoassay.
    Møller Sørensen N; Blincko S; Dinsmore E; Weerakoon A; Lally J; Jensen V; Nielsen HJ; Christensen IJ; Rodgers BC; Dowell B; Brünner N; Davis G
    Tumour Biol; 2006; 27(6):319-28. PubMed ID: 17033201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of 7 new monoclonal antibodies to tissue inhibitor of metalloproteinases-1.
    Møller Sørensen N; Dowell BL; Stewart KD; Jensen V; Larsen L; Lademann U; Murphy G; Nielsen HJ; Brünner N; Davis GJ
    Tumour Biol; 2005; 26(2):71-80. PubMed ID: 15870512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.
    Holten-Andersen MN; Christensen IJ; Nielsen HJ; Lilja H; Murphy G; Jensen V; Brünner N; Piironen T
    Clin Chem; 2002 Aug; 48(8):1305-13. PubMed ID: 12142388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.
    Holten-Andersen MN; Murphy G; Nielsen HJ; Pedersen AN; Christensen IJ; Høyer-Hansen G; Brünner N; Stephens RW
    Br J Cancer; 1999 May; 80(3-4):495-503. PubMed ID: 10408859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
    Holten-Andersen MN; Stephens RW; Nielsen HJ; Murphy G; Christensen IJ; Stetler-Stevenson W; Brünner N
    Clin Cancer Res; 2000 Nov; 6(11):4292-9. PubMed ID: 11106246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saliva and plasma TIMP-1 in patients with colorectal cancer: a prospective study.
    Holten-Andersen L; Christensen IJ; Jensen SB; Reibel J; Laurberg S; Nauntofte B; Brünner N; Nielsen HJ
    Scand J Gastroenterol; 2012 Oct; 47(10):1234-41. PubMed ID: 22871105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. a validation study.
    Holten-Andersen M; Christensen IJ; Nilbert M; Bendahl PO; Nielsen HJ; Brünner N; Fernebro E;
    Eur J Cancer; 2004 Jan; 40(1):64-72. PubMed ID: 14687791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microplate chemiluminescence enzyme immunoassay for the quantitative analysis of tissue inhibitor of metalloproteinases I].
    Hou J; Zhang J; Liu J; Zhao J; Guo JX; Cheng L; Xu J; Liu AX; Song YJ; Li BA; Wei HS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):298-300. PubMed ID: 24579481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma TIMP-1 in patients with colorectal adenomas: a prospective study.
    Holten-Andersen MN; Fenger C; Nielsen HJ; Rasmussen AS; Christensen IJ; Brünner N; Kronborg O
    Eur J Cancer; 2004 Sep; 40(14):2159-64. PubMed ID: 15341992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.
    Frederiksen CB; Lomholt AF; Lottenburger T; Davis GJ; Dowell BL; Blankenstein MA; Christensen IJ; Brunner N; Nielsen HJ
    Int J Biol Markers; 2008; 23(1):42-7. PubMed ID: 18409150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Caspersen MB; Sørensen NM; Schrohl AS; Iversen P; Nielsen HJ; Brünner N
    Int J Biol Markers; 2007; 22(2):89-94. PubMed ID: 17549663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.
    Christensen IJ; Brünner N; Dowell B; Davis G; Nielsen HJ; Newstead G; King D
    Anticancer Res; 2015 Sep; 35(9):4935-41. PubMed ID: 26254391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer.
    Lipton A; Ali SM; Leitzel K; Demers L; Evans DB; Hamer P; Brown-Shimer S; Pierce K; Carney W
    Cancer; 2007 May; 109(10):1933-9. PubMed ID: 17407159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
    Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
    Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables.
    Işlekel H; Oktay G; Terzi C; Canda AE; Füzün M; Küpelioğlu A
    Cell Biochem Funct; 2007; 25(4):433-41. PubMed ID: 16615041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma or serum TIMP-1 is a predictor of survival outcomes in colorectal cancer: a meta-analysis.
    Lee JH; Choi JW; Kim YS
    J Gastrointestin Liver Dis; 2011 Sep; 20(3):287-91. PubMed ID: 21961097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer.
    Holten-Andersen MN; Christensen IJ; Nielsen HJ; Stephens RW; Jensen V; Nielsen OH; Sørensen S; Overgaard J; Lilja H; Harris A; Murphy G; Brünner N
    Clin Cancer Res; 2002 Jan; 8(1):156-64. PubMed ID: 11801553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.